A class of semiparametric transormation frailty models with application to estimating treatment effects and heterogenity in aids clinical traials
DOI10.1080/03610920008832531zbMATH Open1061.62563OpenAlexW2004760723MaRDI QIDQ4548231FDOQ4548231
Authors: Qiming Liao, Victor G. DeGruttola
Publication date: 2000
Published in: Communications in Statistics: Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610920008832531
Recommendations
- A general transformation class of semiparametric cure rate frailty models
- A semi-parametric transformation frailty model for semi-competing risks survival data
- A General Class of Semiparametric Transformation Frailty Models for Nonproportional Hazards Survival Data
- A Bayesian semiparametric transformation model incorporating frailties
- Regression analysis of multivariate current status data with semiparametric transformation frailty models
- Semi‐parametric estimation of covariate effects using the positive stable frailty model
- Frailty modelling approaches for semi-competing risks data
- Analysis of clustered interval‐censored data using a class of semiparametric partly linear frailty transformation models
Time series, auto-correlation, regression, etc. in statistics (GARCH) (62M10) Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in multivariate analysis (62H12)
Cites Work
- Partial likelihood
- Best Linear Unbiased Estimation and Prediction under a Selection Model
- Analysis of transformation models with censored data
- Some recent developments for regression analysis of multivariate failure time data
- Survival models for heterogeneous populations derived from stable distributions
- Estimating equations for hazard ratio parameters based on correlated failure time data
Cited In (3)
This page was built for publication: A class of semiparametric transormation frailty models with application to estimating treatment effects and heterogenity in aids clinical traials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4548231)